NOTE 9. SEGMENT INFORMATION

 

Our results of operations for the years ended December 31, 2024 and 2023 represent a single operating and reporting segment referred to as Contract Manufacturing within the EMS industry. The Company operates in the Medical Device, Medical Imaging, Aerospace and Defense, and Industrial markets with over 50% of its net sales coming from the medical-related markets. We strategically direct production between our various manufacturing facilities based on a number of considerations to best meet our customers’ needs. Our plants generate net sales over several of the markets the Company servers. We share resources for sales, marketing, engineering, supply chain, information services, human resources, payroll, and all corporate accounting functions. Our chief operating decision maker (the “CODM”) is the Company’s President and Chief Executive Officer. The CODM regularly evaluates financial information on a consolidated basis to assess performance and allocate resources.

 

The following table presents selected financial information with respect to the Company’s single operating segment for the years ended December 31, 2024 and 2023:

 

   2024   2023 
         
Net sales  $128,133   $139,332 
Cost of goods sold   111,411    116,228 
Gross profit   16,722    23,104 
Operating expenses:          
Selling   3,446    3,598 
General and administrative   11,709    12,354 
Research and development   1,191    1,199 
Restructuring charges   571      
Total operating expenses   16,917    17,151 
(Loss) income from operations   (195)   5,953 
Other expense:          
Interest expense   (744)   (487)
(Loss) income before income taxes   (939)   5,466 
Income tax expense (benefit)   356    (1,408)
Net (loss) income  $(1,295)  $6,874 

 

 

The Company’s long-lived tangible assets, including the Company’s operating lease assets recognized on the consolidated balance sheets were located as follows:

 

 SCHEDULE OF LONG LIVED TANGIBLE ASSETS

   2024   2023 
United States  $10,429   $9,421 
Mexico   2,445    2,870 
China   1,497    1,139 
Total long-lived tangible assets  $14,371   $13,430 

 

Export net from our U.S. domestic operations represent approximately 3.4% and 4.1% of consolidated net sales for the years ended December 31, 2024 and 2023, respectively. Net sales by our major EMS industry markets for the years ended December 31, 2024 and 2023 are as follows:

 

 

   2024   2023 
Medical Device  $34,636   $38,758 
Medical Imaging   37,492    39,908 
Industrial   35,517    40,113 
Aerospace and Defense   20,488    20,553 
Total net sales  $128,133   $139,332 

 

Free Sentinel

Want the next NORTECH SYSTEMS INC segments disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment NORTECH SYSTEMS INC's next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.